Bluesky Explorer

#AXDX

Latest posts tagged with #AXDX on Bluesky

Trending

#Ukraine Conflict #U.S. Foreign Policy #F1 #Chinese Grand Prix #SNL #Venezuela Baseball #AEW Collision #Six Nations #Newcastle United #Arsenal vs Everton #Ukraine Conflict #U.S. Foreign Policy #F1 #Chinese Grand Prix #SNL #Venezuela Baseball #AEW Collision #Six Nations #Newcastle United #Arsenal vs Everton

Posts tagged #AXDX

Market Wire News

@marketwirenews.com

10 months ago

Just In: ( NASDAQ: #AXDX ) AXDX - Historical Earnings Price Analysis

0 0 0 0

Market Wire News

@marketwirenews.com

10 months ago

JUST IN: ( NASDAQ: #AXDX ) AXDX - Historical Price Movements Surrounding Earnings

1 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

10 months ago

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Thu May 8th - #ZGN #UHG #TLS #SBET #QNST #MFH #LILIAK #INGN #ERII #DCBO #FGTS #AXDX #CEIX #TLYS #SAR #LUCK #HIPO #ASPN #dCODI - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

@stocktitan.net

10 months ago

Preview

Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets Accelerate Diagnostics (NASDAQ: AXDX) has filed for Chapter 11 bankruptcy protection and announced plans to sell substantially all its assets. The company has secured a $12.5 million debtor-in-possession (DIP) financing facility to maintain operations during the proceedings. Accelerate has agreed to terms with Indaba Capital Management, a majority holder of the company's secured notes, for a "stalking horse" bid to acquire its assets. The purchase price includes a $36.9 million credit bid of Indaba's existing secured notes and DIP financing, along with assumed liabilities and excluded cash for company wind-down. The sale process will be conducted under Section 363 of the Bankruptcy Code, allowing for potential higher or better offers through a court-supervised auction.

#AXDX Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets

www.stocktitan.net/news/AXDX/accelerate-dia...

0 0 0 0

@stocktitan.net

11 months ago

Preview

Revolutionary 4.5-Hour Blood Test System Heads to FDA: Accelerate Diagnostics Targets $62B Sepsis Market New WAVE system delivers antimicrobial susceptibility results in just 4.5 hours, targeting the $62B sepsis market. Game-changing technology for faster patient treatment.

#AXDX Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance

www.stocktitan.net/news/AXDX/accelerate-dia...

0 0 0 0

@stocktitan.net

11 months ago

Preview

Accelerate Diagnostics Q4 Earnings Alert: Revenue Drops as Losses Mount to $50M Accelerate Diagnostics faces headwinds with Q4 sales down to $2.8M and widening losses. Despite cost cuts, cash position declined to $16.3M amid ongoing operational challenges.

#AXDX Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results

www.stocktitan.net/news/AXDX/accelerate-dia...

0 0 0 0

@stocktitan.net

1 year ago

Preview

Accelerate Diagnostics Reports Mixed 2024 Results: Consumables Up 3% Despite Revenue Dip to $11.7M AXDX maintains 350 revenue-generating Pheno instruments, secures 75% customer retention for WAVE launch. Clinical trials show promising 4.5-hour result time, FDA submission planned Q1 2025.

#AXDX Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

www.stocktitan.net/news/AXDX/accelerate-dia...

0 0 0 0